Stock listing

BM8 Stock Price, News, Filings & Events — Biomarin Pharmaceutical Inc.

Selected listing: BM8 · TRADEGATE · EUR · DE

BM8:TRADEGATE represents BioMarin Pharmaceutical Inc., a company focused on developing innovative biopharmaceuticals for serious diseases and medical conditions. The company is known for its commitment to advancing therapies for rare genetic disorders and has a robust pipeline of products. Recent news highlights ongoing clinical trials and regulatory updates that may impact its market position. Investors can find relevant filings and upcoming events that provide insights into the company's strategic direction and performance in the biopharmaceutical sector.

BM8:TRADEGATEEURDEUpdated July 20, 2026
Biomarin Pharmaceutical Inc. logo
Ticker
BM8:TRADEGATE
Asset type
Stock
Market cap
$11.40B
Sector
Health Technology
Industry
Biotechnology
Exchange
TRADEGATE
Currency
EUR

Biomarin Pharmaceutical Inc. BM8:TRADEGATE stock context

BM8:TRADEGATE represents BioMarin Pharmaceutical Inc., a company focused on developing innovative biopharmaceuticals for serious diseases and medical conditions. The company is known for its commitment to advancing therapies for rare genetic disorders and has a robust pipeline of products. Recent news highlights ongoing clinical trials and regulatory updates that may impact its market position. Investors can find relevant filings and upcoming events that provide insights into the company's strategic direction and performance in the biopharmaceutical sector.

Research Biomarin Pharmaceutical Inc.

Alternate listings